Cargando…
Current perspective of new anti-Wolbachial and direct-acting macrofilaricidal drugs as treatment strategies for human filariasis
Filarial diseases like lymphatic filariasis and onchocerciasis belong to the Neglected Tropical Diseases and remain a public health problem in endemic countries. Lymphatic filariasis and onchocerciasis can lead to stigmatizing pathologies and present a socio-economic burden for affected people and t...
Autores principales: | Ehrens, Alexandra, Hoerauf, Achim, Hübner, Marc P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006451/ https://www.ncbi.nlm.nih.gov/pubmed/35463816 http://dx.doi.org/10.3205/id000079 |
Ejemplares similares
-
Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections
por: Schiefer, Andrea, et al.
Publicado: (2020) -
Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis
por: TAYLOR, MARK J., et al.
Publicado: (2014) -
Macrofilaricidal efficacy of single and repeated oral and subcutaneous doses of flubendazole in Litomosoides sigmodontis infected jirds
por: Hübner, Marc P., et al.
Publicado: (2019) -
Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro
por: Hübner, Marc P., et al.
Publicado: (2020) -
Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host
por: Albers, Anna, et al.
Publicado: (2012)